A role for liposomes in genetic vaccination

Vaccine

Volumn 20, Issue SUPPL. 5, 2002, Pages

  Gregoriadis, Gregory ^a,b   Bacon, Andrew ^b   Caparros Wanderley, Wilson ^b   McCormack, Brenda ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Lipoxen Technologies Ltd   (United Kingdom)

Author keywords

Antigen presenting cells; Genetic vaccination; Liposomes

Indexed keywords

1,2 DIOLEOYL 3 (TRIMETHYLAMMONIUM)PROPANE; 1,2 DIOLEOYL 3 DIMETHYLAMMONIUM PROPANE; 3 (N,N DIMETHYLAMINOETHANE)CARBONYLCHOLESTEROL; BACTERIAL PROTEIN; CARRIER PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA VACCINE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; HEPATITIS B SURFACE ANTIGEN; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN G; LIPOSOME; LUCIFERASE; NAKED DNA; NUCLEASE; OCTADECYLAMINE; OVALBUMIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PLASMID DNA; UNCLASSIFIED DRUG; CYTOKINE;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA DEGRADATION; DRUG ADMINISTRATION ROUTE; FREEZE DRYING; GENE TARGETING; GENE THERAPY; GENETIC CODE; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; INGUINAL LYMPH NODE; INJECTION SITE; LYMPH NODE; LYMPHATIC DRAINAGE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; SPLEEN; TISSUE; VACCINATION; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; DRUG EFFECT; GENETICS; IMMUNOLOGY; METHODOLOGY; MOUSE; PLASMID;

ANIMALS; ANTIBODY FORMATION; ANTIGEN-PRESENTING CELLS; CYTOKINES; DRUG ADMINISTRATION ROUTES; IMMUNITY, CELLULAR; LIPOSOMES; MICE; PLASMIDS; VACCINATION; VACCINES, DNA;

EID: 0037146918     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00514-5     Document Type: Short Survey

References (30)

1. Powel MF, Newman MJ, editors. Vaccine Design: The Subunit and Adjuvant Approach. New York: Plenum Press; 1995.
2. Gregoriadis G, McCormack B, Allison AC, Poste G, editors. New Generation Vaccines: The Role of Basic Immunology. New York: Plenum Press; 1993.
3. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol. Today. 11:1990;89-97.
4. Glück R., Mischler R., Brantschen S., Just M., Althans B., Cryz S.J. Jr. Immunopotentiating reconstituted influenza virome vaccine delivery system for immunization against hepatitis A. J. Clin. Invest. 90:1992;2491-2495.
5. Davis H.L., Whalen R.G., Demeneix B.A. Direct gene transfer in skeletal muscle in vivo: factors influencing efficiency of transfer and stability of expression. Hum. Gene Ther. 4:1993;151-156.
6. Manickan E., Karem K.L., Rouse B.T. DNA vaccines - a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17:1997;139-154.
7. Chattergoon M., Boyer J., Weiner D.B. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J. 11:1997;754-763.
8. Gregoriadis G. Genetic vaccines: strategies for optimisation. Pharm. Res. 15:1998;661-670.
9. Lewis P.J., Babiuk L.A. DNA vaccines: a review. Adv. Virus Res. 54:1999;129-188.
10. Tang D.C., Devit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
11. Ulmer J.B., Donnelly J., Parker S.E.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
12. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11478-11482.
13. Wang B., Ugen K., Srikantan V.et al. Gene inoculation generates immune responses against HIV-I. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4156-4160.
14. Davis H.L., Michel M.L., Mancini M., Schleef M., Whalen R.G. Direct gene transfer in skeletal muscle: plasmid DNA based immunization against the hepatitis B virus surface antigen. Vaccine. 12:1994;1503-1509.
15. Conry R., LoBuglio A., Loechel F.et al. A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Cancer Gene. Ther. 2:1995;33-38.
16. Bright R.K., Beames B., Shearer M.H., Kennedy R.C. Protection against lethal tumor challenge with SV40-transformed cells by the direct injection of DNA encoding SV-40 large tumor antigen. Cancer Res. 56:1996;1126-1130.
17. Spier E. International meeting on the nucleic acid vaccines for the prevention of infectious disease and regulatory nuclear acid (DNA) vaccines. Vaccine. 14:1996;1285-1288. [Meeting report].
18. Scheef M., Moritz P., Schoor J. How to produce nucleic acids for human gene therapy and genetic vaccination under full CGMP pharmaceutical manufacturing conditions. Pharm. Sci. 4(Suppl.):1996;S25.
19. Matzinger P. Tolerance, danger and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
20. Gregoriadis G., Saffie R., de Souza B. Liposome-mediated DNA vaccination. FEBS Lett. 402:1997;107-110.
21. Gregoriadis G., Saffie R., Hart S.L. High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency. J. Drug Targeting. 3:1996;469-475.
22. Gregoriadis G. Engineering targeted liposomes: progress and problems. Trends Biotechnol. 13:1995;527-537.
23. Gregoriadis G, McCormack B, Obrenovic M, Perrie Y, Entrapment of plasmid DNA vaccines into liposomes by dehydration/rehydration. In: Lowerie DB, Whalen R, editors. Methods in Molecular Medicine, DNA Vaccines: Methods and Protocols. Totowa (NJ): Humana Press Inc.; 1999. p. 305-12.
24. Gregoriadis G., McCormack B., Obrenovic M., Saffie R., Zadi B., Perrie Y. Liposomes as immunological adjuvants and vaccine carriers. Methods. 19:1999;156-162.
25. Felgner P.L., Rhodes G. Gene therapeutics. Nature. 349:1991;351-352.
26. Perrie Y., Gregoriadis G. Liposome-entrapped plasmid DNA: characterization studies. Biochim. Biophys. Acta. 1475:2000;125-132.
27. Perrie Y., Gregoriadis G. Liposome mediated DNA vaccination: the effect of vesicle composition. Vaccine. 19:2001;3301-3310.
28. Velinova M., Read N., Kirby C., Gregoriadis G. Morphological observations on the fate of liposomes in the regional lymphs nodes after footpad injection into rats. Biochim. Biophys. Acta. 1299:1996;207-215.
29. Szoka F.C., Xu Y., Zelpati O. How are nucleic acids released in cells from cationic lipid-nucleic acid-complexes? J. Liposome Res. 6:1996;567-587.
30. Bacon A., Caparrós-Wanderley W., Zadi B., Gregoriadis G. Induction of a cytotoxic T lymphocyte (CTL) response to plasmid DNA delivered by Lipodine™ J. Liposome Res. 12:2002;173-183.